NexStep Medical received the FDA 510(k) approval for the All’InCath 035M balloon dilatation catheter used for percutaneous transluminal angioplasty (PTA).
“After all these years of development, a journey fraught with numerous pitfalls and, finally, always suitable and exploitable solutions, I would like to sincerely thank the whole team for its confidence, its commitment and the excellent work that was carried out. Our work in developing Pierre Sarradon’s All’InCath 035M device, improving the service provided to practitioners & patients, has enabled us to reach a decisive stage: NexStep Medical is authorized to sell and operate the All’InCath 035M in the United States!” said Philippe Urbain, President and co-founder of NexStep Medical.
About NexStep Medical
NexStep is a privately-held medical device company that has been developing products in the area of percutaneous transluminal angioplasty since 2014.
For more details, please contact Philippe Urbain, President and co-founder of NexStep Medical.
For more information, visit www. NexStepmedical.com